 |
|
News
BIT鈥檚 1st Annual International Congress of Biotherapy Grand Opening in Beijing
2017-03-29
In the morning of March 29th, sponsored by the world high tech Association and hosted by BIT Group, the 2017 BIT鈥檚 1st Annual International Congress of Biotherapy and two parallel branches BIT鈥檚 Annual International Congress of Antibody-2017 and BIT鈥檚 Annual World Congress of Vaccine-2017 has opened in Be ijing Wanda Royal hotel. Dr. Mei Xiaodan, the executive chairman of the general assembly, chairman of BIT Group, delivered opening speech. Other important leaders and guests attended the opening ceremony as well.
The conference will be held for three days and will hold nearly 20 sub forums such as gene therapy, cell therapy, tumor immunotherapy, protein and peptide drug research and development, antibody drug research and development, and new vaccines. The organizing committee invited the experts from China and abroad, 150 industry leading enterprise executives had wonderful sessions, 70 exhibitors, and nearly 1000 field professionals from more than 30 countries and regions participated exhibition. The conference will focus on the latest developments in the forefront of the field, disseminating the latest information in the industry, demonstrating new products and technologies that will have a profound impact on the world's biological treatment industry.
The conference will be held for three days and will hold nearly 20 sub forums such as gene therapy, cell therapy, tumor immunotherapy, protein and peptide drug research and development, antibody drug research and development, and new vaccines. The organizing committee invited the experts from China and abroad, 150 industry leading enterprise executives had wonderful sessions, 70 exhibitors, and nearly 1000 field professionals from more than 30 countries and regions participated exhibition. The conference will focus on the latest developments in the forefront of the field, disseminating the latest information in the industry, demonstrating new products and technologies that will have a profound impact on the world's biological treatment industry.
